Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Caen

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Blood|May 1, 1987
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to HisM C Owen, J Y Borg, C Soria, et al.
The Journal of Clinical Investigation|April 1, 1988
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to SerJ Y Borg, M C Owen, C Soria, et al.
American Journal of Nephrology|January 1, 1991
Heparin cofactor II in adult glomerulopathy and nephrotic syndromeM A Pech, G Rostoker, C Soria, et al.
American Journal of Hematology|October 1, 1992
Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulantJ F Schved, J C Gris, V Ollivier, et al.
Lancet (London, England)|October 28, 1989
Increase of endothelial cell growth by sera from diabetic patients with proliferative retinopathyH Setiadi, M P Wautier, P J Guillausseau, et al.
La Nouvelle Presse Medicale|October 3, 1981
[Autoimmune thrombocytopenic purpura. Clinical and therapeutic retrospective study of 544 cases (author's transl)]G Tobelem, C Chastang, B Asselain, et al.
Thrombosis Research|November 15, 1984
Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activatorF W Dunn, K Deguchi, J Soria, et al.
Journal of Dairy Science|January 1, 1993
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activitiesA M Fiat, D Migliore-Samour, P Jollès, et al.
American Journal of Hematology|June 1, 1987
Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylationsF Rendu, J Maclouf, J M Launay, et al.
Blood|October 15, 1993
Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structureJ P Collet, J Soria, M Mirshahi, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Blood|May 1, 1987
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to HisM C Owen, J Y Borg, C Soria, et al.
The Journal of Clinical Investigation|April 1, 1988
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to SerJ Y Borg, M C Owen, C Soria, et al.
American Journal of Nephrology|January 1, 1991
Heparin cofactor II in adult glomerulopathy and nephrotic syndromeM A Pech, G Rostoker, C Soria, et al.
American Journal of Hematology|October 1, 1992
Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulantJ F Schved, J C Gris, V Ollivier, et al.
Lancet (London, England)|October 28, 1989
Increase of endothelial cell growth by sera from diabetic patients with proliferative retinopathyH Setiadi, M P Wautier, P J Guillausseau, et al.
La Nouvelle Presse Medicale|October 3, 1981
[Autoimmune thrombocytopenic purpura. Clinical and therapeutic retrospective study of 544 cases (author's transl)]G Tobelem, C Chastang, B Asselain, et al.
Thrombosis Research|November 15, 1984
Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activatorF W Dunn, K Deguchi, J Soria, et al.
Journal of Dairy Science|January 1, 1993
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activitiesA M Fiat, D Migliore-Samour, P Jollès, et al.
American Journal of Hematology|June 1, 1987
Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylationsF Rendu, J Maclouf, J M Launay, et al.
Blood|October 15, 1993
Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structureJ P Collet, J Soria, M Mirshahi, et al.
Pageof 15